New Hepatitis B Screening Recommendations for 2023

By Matt Zeitler, MD
on June 05, 2023

We know that chronic hepatitis B infection can lead to substantial morbidity and mortality. While there is no cure, antiviral treatment, monitoring, and liver cancer surveillance can improve outcomes for people living with hepatitis B. Additionally, effective preventative hepatitis B vaccines are available.

Until recently, guidelines recommended that only people at high risk of infection be screened for hepatitis B virus (HBV). Under that policy, we missed a lot of people: only an estimated 1 in 3 people in the U.S. with hepatitis B are aware they are infected. 

Navigating Cancer Screenings With Your Transgender Patients

By Matt Zeitler, MD
on April 10, 2023

Cancer screening is a critical part of primary care practice, and most of us can recite guidelines in our sleep. That said, cancer screening can feel a little tricky in our transgender population, especially when we are still learning to navigate this sensitive topic as a general part of our practice.